Geovis Insighter Technology
920116
ESKONJAC
839273
Xdc Industries(Shenzhen)Limited
300615
Wuxi Online Offline Communication Information Technology Co., Ltd.
300959
Shanghai DOBE Cultural & Creative Industry Development
300947
CN Stock MarketDetailed Quotes
600329 Tianjin Pharmaceutical Da Ren Tang Group Corporation
- 30.54
- -0.26-0.84%
Not Open Jan 2 15:00 CST
23.52BMarket Cap25.22P/E (TTM)
31.20High30.39Low53.82KlotVolume30.85Open30.80Pre Close165.61MTurnover0.95%Turnover Ratio23.84P/E (Static)770.16MShares39.0552wk High3.66P/B17.32BFloat Cap22.1252wk Low33.88Limit Up567.09MShs Float53.86Historical High27.72Limit Down2.63%Amplitude-3.05Historical Low1.28Dividend TTM30.77Avg Price30.04KlotAsk4.19%Div YieldTTM100Lot Size22.81KlotBid
Tianjin Pharmaceutical Da Ren Tang Group Corporation Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -3.14%5.61B | -3.02%3.96B | -3.19%2.09B | -0.33%8.22B | 4.13%5.79B | 8.31%4.09B | 14.03%2.15B | 19.42%8.25B | 3.94%5.56B | 3.69%3.77B |
| Operating revenue | -3.14%5.61B | -3.02%3.96B | -3.19%2.09B | -0.33%8.22B | 4.13%5.79B | 8.31%4.09B | 14.03%2.15B | 19.42%8.25B | 3.94%5.56B | 3.69%3.77B |
| Other operating revenue | ---- | -15.24%5.37M | ---- | -9.16%16.23M | ---- | -28.99%6.34M | ---- | 16.58%17.87M | ---- | -0.40%8.92M |
| Total operating cost | -3.58%4.85B | -3.72%3.34B | -4.42%1.72B | -1.77%7.36B | 2.39%5.03B | 4.56%3.47B | 6.61%1.8B | 19.70%7.49B | 3.50%4.91B | 3.17%3.32B |
| Operating cost | -10.36%2.86B | -8.62%1.99B | -8.42%1.01B | -7.09%4.6B | -2.68%3.19B | -2.13%2.17B | -3.61%1.1B | 19.40%4.96B | 5.81%3.28B | 5.71%2.22B |
| Operating tax surcharges | 10.72%58.71M | 8.52%43.74M | 7.74%22.61M | 3.07%79.05M | 0.33%53.02M | 4.43%40.31M | 19.04%20.99M | 19.60%76.69M | 9.18%52.85M | 11.57%38.6M |
| Operating expense | 1.41%1.48B | -3.27%1.03B | -6.27%553.35M | 7.98%2.13B | 16.86%1.45B | 24.52%1.07B | 38.65%590.35M | 26.52%1.97B | 2.93%1.24B | 2.47%855.8M |
| Administration expense | 35.58%344.65M | 50.62%236.44M | 63.26%111.49M | 0.99%381.63M | -5.76%254.19M | -10.78%156.98M | -28.54%68.29M | 1.25%377.89M | -13.70%269.72M | -12.70%175.94M |
| Financial expense | 136.31%5.85M | 91.59%-1.41M | 116.36%688.58K | 60.72%-15.62M | 50.84%-16.13M | 35.45%-16.82M | 64.38%-4.21M | 12.84%-39.77M | -39.97%-32.8M | -30.33%-26.05M |
| -Interest expense (Financial expense) | 6.46%29.63M | 5.59%17.95M | -15.17%6.83M | 249.15%35.85M | 626.10%27.83M | 975.31%17M | --8.06M | 249.61%10.27M | 30.49%3.83M | --1.58M |
| -Interest Income (Financial expense) | 43.91%-25.82M | 44.35%-19.88M | 44.03%-6.88M | 2.64%-54.64M | -15.17%-46.03M | -21.10%-35.73M | 6.05%-12.29M | -11.18%-56.12M | -50.42%-39.97M | -48.75%-29.51M |
| Research and development | 14.22%98.8M | -10.33%46.65M | 2.23%24.74M | 20.56%184.63M | -6.25%86.49M | -5.70%52.03M | 25.15%24.2M | -4.91%153.15M | -2.34%92.26M | -16.66%55.17M |
| Credit Impairment Loss | -76.23%-29.35M | 10.99%-8.68M | 6.15%-5.93M | -833.50%-23.3M | -208.27%-16.66M | -107.88%-9.76M | 37.34%-6.32M | 67.15%-2.5M | 76.37%-5.4M | 37.93%-4.69M |
| Asset Impairment Loss | 27.44%-12.47M | -166.45%-15.76M | -237.21%-1.45M | -28.61%-71.86M | -19.35%-17.18M | 33.83%-5.91M | 123.72%1.05M | -440.31%-55.87M | -13.76%-14.4M | -34.86%-8.94M |
| Other net revenue | -20.64%154.98M | -34.89%124.5M | -23.83%78.68M | 5.03%234.86M | -0.41%195.28M | 99.62%191.23M | 197.55%103.29M | 2.21%223.61M | 33.46%196.08M | -14.55%95.8M |
| Invest income | -18.70%178.37M | -33.34%132.39M | -23.11%77.9M | 12.36%308.11M | 5.27%219.4M | 89.04%198.61M | 109.82%101.32M | 28.45%274.22M | 27.46%208.4M | -6.08%105.06M |
| -Including: Investment income associates | -25.07%158.32M | -37.75%121.57M | -27.54%72.6M | 49.83%294.58M | 60.86%211.28M | 94.09%195.28M | 125.57%100.2M | 5.94%196.61M | -11.87%131.35M | -8.26%100.61M |
| Asset deal income | -27.26%108.59K | -126.87%-44.06K | -356.00%-171.38K | -86.22%149.29K | --149.29K | --164.01K | --66.95K | -91.20%1.08M | ---- | ---- |
| Other revenue | 91.42%18.33M | 104.31%16.61M | 15.98%8.32M | 226.09%21.76M | 28.08%9.58M | 86.06%8.13M | 655.41%7.17M | -38.79%6.67M | -1.49%7.48M | -12.64%4.37M |
| Operating profit | -4.42%919.43M | -7.55%747.85M | -3.04%440.78M | 11.93%1.1B | 13.14%961.95M | 46.73%808.89M | 95.40%454.6M | 13.08%980.05M | 12.45%850.22M | 3.02%551.27M |
| Add:Non operating Income | 307.03%7.22M | 34.01%1.03M | 53.64%773.36K | 5.84%3.08M | 302.78%1.77M | 131.34%768.66K | 96.10%503.35K | -68.78%2.91M | -95.55%440.62K | -92.92%332.26K |
| Less:Non operating expense | 32.97%3.25M | 32.64%1.23M | 226.50%1.01M | 69.20%4.7M | -11.02%2.44M | -48.14%925.54K | 210.40%310.03K | -13.43%2.78M | 33.07%2.74M | 637.68%1.78M |
| Total profit | -3.94%923.41M | -7.55%747.65M | -3.13%440.54M | 11.75%1.1B | 13.37%961.29M | 47.09%808.74M | 95.36%454.79M | 12.30%980.19M | 11.00%847.92M | 1.90%549.82M |
| Less:Income tax cost | 9.24%130.28M | 2.34%96.48M | 0.26%57.15M | 18.45%126.66M | 17.26%119.26M | 31.19%94.27M | 86.57%57.01M | 24.44%106.93M | 17.02%101.71M | 7.31%71.86M |
| Net profit | -5.81%793.13M | -8.86%651.17M | -3.62%383.38M | 10.93%968.71M | 12.84%842.02M | 49.48%714.47M | 96.68%397.78M | 10.98%873.26M | 10.22%746.21M | 1.14%477.97M |
| Net profit from continuing operation | -5.81%793.13M | -8.86%651.17M | -3.62%383.38M | 10.93%968.71M | 12.84%842.02M | 49.48%714.47M | 96.68%397.78M | 10.98%873.26M | 10.22%746.21M | 1.14%477.97M |
| Less:Minority Profit | 33.69%-10.72M | 18.41%-6.55M | -31.23%-3.94M | -257.03%-18M | -193.72%-16.17M | -187.41%-8.02M | -213.75%-3.01M | -35.35%11.46M | 11.35%17.25M | -8.68%9.18M |
| Net profit of parent company owners | -6.33%803.86M | -8.97%657.72M | -3.36%387.33M | 14.49%986.71M | 17.73%858.19M | 54.12%722.49M | 100.79%400.79M | 12.05%861.79M | 10.20%728.96M | 1.35%468.79M |
| Earning per share | ||||||||||
| Basic earning per share | -6.31%1.04 | -9.57%0.85 | -3.85%0.5 | 14.29%1.28 | 16.84%1.11 | 54.10%0.94 | 100.00%0.52 | 12.00%1.12 | 10.47%0.95 | 1.67%0.61 |
| Diluted earning per share | -6.31%1.04 | -9.57%0.85 | -3.85%0.5 | 15.32%1.28 | 18.09%1.11 | 54.10%0.94 | 100.00%0.52 | 11.00%1.11 | 9.30%0.94 | 1.67%0.61 |
| Other composite income | -181.19%-680.18K | -229.87%-1.78M | -1,143.82%-1.07M | 541.60%4.81M | -51.27%837.8K | 231.83%1.37M | 130.01%102.09K | -114.64%-1.09M | 117.88%1.72M | 15.17%-1.04M |
| Other composite income of parent company owners | -181.19%-680.18K | -229.87%-1.78M | -1,143.82%-1.07M | 541.60%4.81M | -51.27%837.8K | 231.83%1.37M | 130.01%102.09K | -114.64%-1.09M | 117.88%1.72M | 15.17%-1.04M |
| Total composite income | -5.98%792.45M | -9.28%649.39M | -3.91%382.32M | 11.62%973.51M | 12.69%842.86M | 50.09%715.84M | 97.06%397.88M | 9.80%872.17M | 12.07%747.93M | 1.18%476.93M |
| Total composite income of parent company owners | -6.50%803.18M | -9.38%655.94M | -3.65%386.26M | 15.20%991.51M | 17.57%859.03M | 54.76%723.86M | 101.19%400.89M | 10.83%860.71M | 12.09%730.68M | 1.39%467.75M |
| Total composite income of minority owners | 33.69%-10.72M | 18.41%-6.55M | -31.23%-3.94M | -257.03%-18M | -193.72%-16.17M | -187.41%-8.02M | -213.75%-3.01M | -35.35%11.46M | 11.35%17.25M | -8.68%9.18M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit China Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
